Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 29, 2024 07:33 ET
NowVertical Group Announces Delay in Annual Filings
NowVertical Group Inc. (TSXV: NOW) (OTCQB: NOWVF), (“NOW” or the “Company”), announces a delay in the filing of its audited annual financial statements, management's discussion and analysis and related chief executive officer (CEO) and chief...
Apr 29, 2024 07:30 ET
Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies
Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that the company has reached target enrollment in the randomized,...
Apr 29, 2024 07:30 ET
KANZHUN LIMITED Files Its Annual Report on Form 20-F
KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and...
Apr 29, 2024 07:30 ET
Beji Varghese Joins FTI Consulting’s Financial Services Practice in Charlotte
FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Beji Varghese as a Senior Managing Director within the firm’s Financial Services practice. His appointment strengthens FTI Consulting’s consumer finance presence in Charlotte and...
Apr 29, 2024 07:30 ET
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market opens on Tuesday, May...
Apr 29, 2024 07:30 ET
Dragonfly Energy to Report First Quarter 2024 Financial and Operational Results on May 14, 2024
Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), maker of Battle Born Batteries® and an industry leader in energy storage, today announced that the Company will release its financial results for the first...
Apr 29, 2024 07:30 ET
Heartland Financial USA, Inc. ("HTLF") Reports Quarterly Results as of March 31, 2024
Heartland Financial USA, Inc. (NASDAQ: HTLF) today reported the following results for the quarter ended March 31, 2024, compared to the quarter ended March 31, 2023: Net income available to common stockholders of $49.7 million compared to $50.8...
Apr 29, 2024 07:30 ET
Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the acceptance of an oral presentation from the Phase 1 portion of the ongoing...
Apr 29, 2024 07:30 ET
OJEMDA™ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rearr
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Day One Biopharmaceuticals for OJEMDA™ (tovorafenib), which is now FDA approved for the treatment of patients six months of age and older with...
Apr 29, 2024 07:30 ET
Streamline Health® Expands eValuator™ Footprint With Existing Client
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its existing contract with a 1,250 bed, Epic-based academic medical...
Apr 29, 2024 07:30 ET
UMB Announces Agreement to Acquire Heartland Financial
UMB Financial Corporation (Nasdaq: UMBF) and Heartland Financial, USA Inc. (Nasdaq: HTLF) announced today that they have entered into a definitive merger agreement under which UMB Financial Corporation (UMB) will acquire Heartland Financial USA,...
Apr 29, 2024 07:30 ET
Zevra Therapeutics’ President and Chief Executive Officer Issues Letter to Stockholders Highlighting Recent Key Accomplishments and Outlook for 2024
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane, Zevra’s President and Chief Executive Officer, has issued a Letter to Stockholders providing a review of...
Apr 29, 2024 07:25 ET
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that important new data on its lead drug...
Apr 29, 2024 07:25 ET
Bullet Blockchain Announces 2023 Financial Results
via NewMediaWire -- Bullet Blockchain, Inc. (“BULT” or the “Company”) (OTC: BULT), a pioneering software development and SaaS company at the forefront of blockchain and Bitcoin ATM technologies, is delighted to report that its fourth-quarter gross...
Apr 29, 2024 07:15 ET
AirBoss Defense Group Receives $45 Million Order for the Bandolier Lightweight Multi-Purpose Energetic System
AirBoss Defense Group (ADG) announced today that it has been awarded a $45 million contract to provide its Bandolier lightweight, multipurpose energetic system to a NATO partner nation. Subject to satisfaction of customary conditions, including...
Apr 29, 2024 07:15 ET
ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of Anavex Life Sciences Corporation (NASDAQ: AVXL)? Did you purchase your shares between February 1, 2022 and January 1, 2024, inclusive? Did you lose money in your investment in Anavex Life...
Apr 29, 2024 07:15 ET
AUTODESK, INC. (NASDAQ: ADSK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Autodesk, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of Autodesk, Inc. (NASDAQ: ADSK)?Did you purchase your shares between June 1, 2023 and April 16, 2024, inclusive?Did you lose money in your investment in Autodesk, Inc.?Do you want to discuss...
Apr 29, 2024 07:15 ET
BLUEBIRD BIO, INC. (NASDAQ: BLUE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds bluebird bio, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of bluebird bio, Inc. (NASDAQ: BLUE)? Did you purchase your shares between April 24, 2023 and December 8, 2023, inclusive? Did you lose money in your investment in bluebird bio, Inc.? Do...
Apr 29, 2024 07:15 ET
COMPASS MINERALS INTERNATIONAL, INC. (NYSE: CMP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Compass Minerals International, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of Compass Minerals International, Inc. (NYSE: CMP)?Did you purchase your shares between November 29, 2023 and March 22, 2024, inclusive?Did you lose money in your investment in Compass...
Apr 29, 2024 07:15 ET
DOXIMITY, INC. (NYSE: DOCS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of Doximity, Inc. (NYSE: DOCS)?Did you purchase your shares between February 9, 2022 and April 1, 2024, inclusive?Did you lose money in your investment in Doximity, Inc.?Do you want to discuss...